Pfizer (NYSE:PFE)

Why Pfizer Is Getting Deeper Into Gene Therapy

Pfizer Inc. (NYSE: PFE) is getting deeper into gene therapy. The U.S. drug giant has acquired a 15% stake in Vivet Therapeutics. On top of the investment in the French ...
Read Full Story »

Pfizer Moves Over Half a Billion for Wilson Disease Treatment

Pfizer Inc. (NYSE: PFE) has announced that it has acquired a 15% equity interest in Vivet and secured an exclusive option to acquire all outstanding shares. Pfizer is looking to ...
Read Full Story »

Big Pharma Short Interest Backs Off, With One Huge Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

After the strong start to the year, the momentum in the big U.S. stock indexes began to slow late in February. Trade concerns and fears of inflation or another recession ...
Read Full Story »

Major Pharma Sees Tremendous Rise in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

As February began, the federal government shutdown was over and the January employment report was stronger than expected, but ongoing concerns about trade and fears of a recession lingered. It ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allscripts, AmeriGas, CVS, IMAX, Kraft Heinz, Marathon Oil, Microsoft, Pfizer and Many More

Stocks were indicated to open higher by over 100 more points on the Dow Jones industrial average and 13 points on the S&P 500 on additional China-trade developments as tariff ...
Read Full Story »

Major Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 15 Best Dividend Stocks for Retirees to Own

There are many types of investors in America. Whether you are in your twenties or retired, it is important to know what strategy is the best fit for your portfolio. ...
Read Full Story »

Why It Is Time to Sell the Rally and Buy Safe Dividend Stocks

After the fourth quarter from hell, when looking at brokerage account statements was a nauseating experience, we had the January to remember, with a huge rally that has gone on ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

Stocks surged higher on Wednesday after strong post-earnings reactions from Apple and Boeing, and then Federal Reserve Chair Jerome Powell helped the markets by indicating that the Fed would be ...
Read Full Story »

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options ...
Read Full Story »

Why Pfizer Fell Short in Q4

Pfizer Inc. (NYSE: PFE) released its fourth-quarter financial results before the markets opened on Tuesday. The pharma giant said that it had $0.64 in earnings per share (EPS) and $14.0 ...
Read Full Story »

What to Expect When Pfizer Reports Tuesday

Pfizer Inc. (NYSE: PFE) is scheduled to release its fourth-quarter financial results before the markets open on Tuesday. Consensus analyst estimates call for $0.64 in earnings per share (EPS) and ...
Read Full Story »

Short Interest Spikes in a Couple Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »